Clin2
NCT06629389Possibly a fitRecruiting

Cannabidiol (Kanbis) for Parkinson's symptoms

Parkinson Disease

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This trial tests whether cannabidiol (CBD) can help with Parkinson's disease symptoms. Researchers want to see if it's safe and effective for people with mild to moderate Parkinson's who are already on stable medications.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
88 people
Ages
40 years to 80 years
Study type
Interventional

Who can take part

  • You are between 40 and 80 years old.
  • You have been diagnosed with Parkinson's disease for at least 5 years and have mild to moderate symptoms.
  • Your Parkinson's medications and doses have not changed in the past month.
  • You do not have dementia, severe depression, or psychosis.
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.
  • You have not had deep brain stimulation surgery for Parkinson's.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07005180Recruiting· Phase 2
Carbon monoxide gas for Parkinson's disease

This trial tests if a low dose of carbon monoxide (HBI-002) is safe and helpful for people with Parkinson's disease. It requires specific health criteria and stable Parkinson's medication.

Fountain Valley, California
NCT06976268Recruiting· Phase 2/Phase 3
Testing BHV-8000 for early Parkinson's disease

This study tests a new once-daily pill called BHV-8000 in people who were recently diagnosed with early Parkinson's disease and are not yet on medication. The goal is to see if it can slow the progression of symptoms and improve quality of life.

Birmingham, Alabama
NCT05882487Not yet recruiting· Early Phase 1
Study drug KL002 for advanced Parkinson’s disease

This early-phase trial tests how safe and potentially effective KL002 is for people with advanced Parkinson’s disease. It may help reduce Parkinson’s movement symptoms, but the main early goal is safety.

Hangzhou, Zhejiang
NCT07157735Recruiting· Phase 2
Testing an anti-inflammatory drug for early Parkinson's disease

This trial tests whether the anti-inflammatory drug dapansutrile can help people with early Parkinson's disease. You would get either dapansutrile or a placebo (a pill with no active drug) to see if it slows the disease.

Cambridge
NCT06732180Recruiting· Phase 1
Testing a new drug (GT-02287) for Parkinson's disease

This trial tests an investigational drug called GT-02287 in people with early-stage Parkinson's disease (diagnosed within the last 7 years). The goal is to see if it is safe and how the body processes it, with a special focus on people with certain genetic changes (GBA1 mutations) that may be linked to Parkinson's.

Darlinghurst, New South Wales
NCT06705517Recruiting
Mediterranean diet study for Parkinson's disease

This trial tests whether a Mediterranean diet can help people with Parkinson's disease. You would either follow your usual diet or switch to a Mediterranean diet for six months and provide blood and stool samples.

Varese, Varese

Hear when a new Parkinson Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.